Background: Escherichia coli (E. coli) is the most commonly isolated bacteria in human pathology. In Morocco the data concerning the nature and the rates of antibiotic resistance of E. coli in both hospitals and city environment remains relatively poor and needs further investigations.
Background
Escherichia coli (E. coli) is a common commensal of the intestine of humans and animals but can also be found in water, soil and vegetation [1] . It is the most frequently isolated bacteria from clinical samples [1] , indeed E. coli is the pathogen most involved in urinary tract infections [2] [3] [4] and one of the common agents responsible for ear infections, sepsis and wound infections [5, 6] . In the developing countries, E. coli represents the agent most commonly responsible for food and waterborne diarrhea and causes high mortality in children under 5 years old [7] .
Escherichia coli dominates the overall spectrum of the bacterial infections in both hospitals and the community [8] . Therefore its susceptibility to antibiotics reflects both the hospital and community antibiotic selection pressure [9] .
The emergence of resistance is a global phenomenon, although the rates of antibiotic resistance remain different between developed and developing countries [10, 11] . This emergence complicates the management of infections and impacts the use of widely prescribed antibiotics in clinical practice such as penicillins, sulfonamides and fluoroquinolones.
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Methods

Materials
The present study was conducted in the bacteriology department of the Rabat Military Teaching Hospital Mohammed V. Retrospectively from April 1, 2012 to July 31, 2013. We included all E. coli isolates received from hospitalized patients and outpatients. We highlight that under Moroccan law no ethical approval is required for a retrospective study based on laboratory data and no consent from patients is necessary to carry out further tests on samples collected for other purposes.
In order to eliminate duplicates, only one strain isolated from the same patient with the same antibiotic susceptibility was included.
Bacterial identification and antimicrobial susceptibility
The identification of bacterial isolates was based on cultural, morphological and biochemical characteristics. Biochemical identification was set up using API20E (bioMérieux SA, Marcy-l'Étoile/France).
Antibiotic susceptibility was determined using the agar diffusion method (Mueller-Hinton medium) and its interpretation was made according to the recommendations of antibiogram committee of the French Society for Microbiology [12] .
Antibiotics tested were: amoxicillin-clavulanic acid, cephalothin, cefoxitin, ceftriaxone, ertapenem, gentamicin, amikacin, norfoloxacin, cotrimoxazole and fosfomycin.
Detection of extended β-lactamases (ESBL) was performed by phenotypic method based on the detection of synergy between amoxicillin-clavulanic acid disc and three discs of third-generation cephalosporins: cefotaxim, ceftazidime and cefepime [12] .
Statistical analysis
The Chi square test was used to compare resistance rates. The difference between the frequencies was considered to be significant when p was <0.05.
Results
During the period of our study, were received at the bacteriology department a total of 32,522 samples. The sex ratio male/female was 1.03 (16,515/16,007 High rates of resistance were found for amoxicillinclavulanic acid (42, 5 %), cefalotin (30, 4 %), norfoloxacin (29, 9 %) and cotrimoxazole (37, 7 %). Table 1 shows the rates of resistance (R + I) within E. coli isolates depending on the nature of patients. Frequencies of resistance among isolates from hospitalized patients were higher than those from outpatients in the case of: amoxicillin-clavulanic acid (p < 0.001), cephalothin (p < 0.001), cefoxitin (p = 0.001), ceftriaxone (p < 0.001), amikacin (p = 0.001) and norfoloxacin (p = 0.003). Table 2 shows the rates of resistance (R + I) of E. coli isolates depending on the nature of sample. Frequencies of resistance among isolates from urine samples were lower than those from others samples in the case of: amoxicillin-clavulanic acid (p < 0.001), cephalothin (p < 0.001), cefoxitin (p = 0.004), ceftriaxone (p < 0.001), gentamicin (p < 0.001) and amikacin (p < 0.001).
The rate of simultaneous resistance to all of the three antibiotics which are most used orally (AMC + SXT + FQ) was 8.3 % in isolates from hospitalized patients compared to 9.9 % outpatients (p = 0.34).
Discussion
In our study E. coli represented over a third of the total isolates of our department. Urinary tract remains the main site of colonization-infection totaling about 82 % of all isolates. These proportions are similar to those found in French and European epidemiological studies [13, 14] .
We recorded important levels of resistance (R + I) for amoxicillin-clavulanic acid (38 % in outpatients and 48.1 % in hospitalized patients) these percentages of resistance are comparable to those of Onerba-Francewith 36 % in city and 45 % in hospital [15] . Rates of resistance (R + I) for AMC in hospitalized patients were higher than those from outpatients (p < 0.001).
ESBL and resistance to fluoroquinolones are the two most worrying phenomena [16] . A review of Moroccan data shows varying levels of frequency of ESBL by region, structures and the size of the populations studied. These rates vary between 7 and 15 % [17, 18] .
Our study showed a 12.4 % rate of ESBL E. coli in hospitalized patients, this rate remains similar to that recorded by a recent study in Rabat [17] and lower than the one recorded in Khartoum-Soudan [8] . ESBL is not limited to health care facilities; international studies show that in community setting rates of ESBL E. coli range from 1.3 to 4.8 % [19] [20] [21] . We recorded a 2.5 % rate of ESBL E. coli in our outpatients.
Fluoroquinolone resistance is associated with the misuse of these molecules in human and veterinary medicine [22] . This resistance varies from one geographic area to another with 10 % in France and United States vs. 40 % in China [15, 23, 24] .
Our study found a rate of resistance of E. coli to fluoroquinolones 29.9 % which is similar to that recorded in Rabat [17] with a frequency of resistance among isolates from hospitalized patients higher than those from outpatients (p = 0.003).
A frequent association between genetic determinants of Qnr and those of ESBL was reported by several studies [25] . In our study we found 43 multiresistant strains (ESBL + FQ resistance), more genetic studies are needed to characterize the nature of fluoroquinolone resistance determinants carried by these strains.
The rate of resistance to aminoglycosides remains relatively low (gentamicin 11.1 %, amikacin 1.3 %) as reported in the literature [8] . Amikacin appears to be the most effective molecule of this class of antibiotics explained by the fact that it is strictly used in hospitals and is rarely used in the first line therapy.
In our study, fosfomycin remains largely active on isolates of E. coli with low resistance rates especially among urine isolates (1.9 %). These results suggest that we should favor the use of fosfomycin as a molecule for the empirical treatment of community urinary infections.
Conclusion
Periodic monitoring of antibiotic resistance in different bacterial isolates has become essential given the constant evolution of the bacterial ecology and the emergence of antibiotic resistance. The high rate of multiresistance shown in this study should encourage us to be more judicious in the use of antibiotics especially in probabilistic treatment. Indeed the 10 % threshold of resistance is substantially exceeded for several antibiotics used in our hospital. The emergence of ESBL in the community is an indicator of the seriousness of this problem which appears not to be limited to health care facilities. 
